ATE317900T1 - Für hm1.24 antigen kodierendes gen und dessen promotor - Google Patents

Für hm1.24 antigen kodierendes gen und dessen promotor

Info

Publication number
ATE317900T1
ATE317900T1 AT99906488T AT99906488T ATE317900T1 AT E317900 T1 ATE317900 T1 AT E317900T1 AT 99906488 T AT99906488 T AT 99906488T AT 99906488 T AT99906488 T AT 99906488T AT E317900 T1 ATE317900 T1 AT E317900T1
Authority
AT
Austria
Prior art keywords
promoter
antigen
gene coding
seq
set forth
Prior art date
Application number
AT99906488T
Other languages
English (en)
Inventor
Toshihiko Ohtomo
Masayuki Tsuchiya
Yasuo Koishihara
Masaaki Kosaka
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE317900T1 publication Critical patent/ATE317900T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3061Blood cells
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99906488T 1998-02-25 1999-02-25 Für hm1.24 antigen kodierendes gen und dessen promotor ATE317900T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6061798 1998-02-25
JP9388398 1998-03-24

Publications (1)

Publication Number Publication Date
ATE317900T1 true ATE317900T1 (de) 2006-03-15

Family

ID=26401695

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99906488T ATE317900T1 (de) 1998-02-25 1999-02-25 Für hm1.24 antigen kodierendes gen und dessen promotor

Country Status (7)

Country Link
US (2) US6613546B1 (de)
EP (1) EP1065269B1 (de)
AT (1) ATE317900T1 (de)
AU (1) AU2640299A (de)
DE (1) DE69929876T2 (de)
ES (1) ES2255247T3 (de)
WO (1) WO1999043803A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080219974A1 (en) * 2002-03-01 2008-09-11 Bernett Matthew J Optimized antibodies that target hm1.24
EP1767625A4 (de) * 2004-06-11 2007-12-05 Ginkgo Biomedical Res Inst Co Aktivitätsregulator für interferonproduzierende zelle
CA2660795C (en) 2006-09-18 2014-11-18 Xencor, Inc. Optimized antibodies that target hm1.24
CA2702939A1 (en) 2007-10-16 2009-04-23 Sbi Biotech Co., Ltd. Anti-bst2 antibody

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3412930B2 (ja) 1993-10-15 2003-06-03 俊夫 平野 プレb細胞増殖支持能を有する膜タンパクポリペプチド及びその遺伝子

Also Published As

Publication number Publication date
DE69929876D1 (de) 2006-04-20
AU2640299A (en) 1999-09-15
WO1999043803A1 (fr) 1999-09-02
US6908750B2 (en) 2005-06-21
EP1065269A1 (de) 2001-01-03
EP1065269B1 (de) 2006-02-15
EP1065269A4 (de) 2003-04-09
US6613546B1 (en) 2003-09-02
US20030180889A1 (en) 2003-09-25
WO1999043803A9 (fr) 2000-06-08
ES2255247T3 (es) 2006-06-16
DE69929876T2 (de) 2006-08-10

Similar Documents

Publication Publication Date Title
EP1439230A3 (de) Menschliche transmembranprotein TMP-2 gen
DE69833784D1 (de) Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
HU9601448D0 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
DE69840230D1 (de) Polypeptide mit prolyldipeptidylaminopeptidase-aktivität und dafür kodierende nukleinsäuren
NZ527971A (en) Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon
ATE317900T1 (de) Für hm1.24 antigen kodierendes gen und dessen promotor
DE69934415D1 (de) Neuartiges collectin
CA2253006A1 (en) .beta.-carotene hydroxylase gene
EP1117682A4 (de) Peptide
ATE412751T1 (de) Menschliche tak1 und für diese kodierende dna
DK1129191T3 (da) Fremgangsmåder til diagnosticering eller behandling af neurologiske sygdomme
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
EP1013665A4 (de) Neue polypeptide mit wasserkanalaktivität und dna sequenzen
DE60234843D1 (de) Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
IL136496A0 (en) Nucleotide sequences encoding the tomato light hypersensitive phenotype, encoded proteins and uses thereof
EP0911408A3 (de) DNA kodierend für eine Serin/Threonin Kinase
SE9801098D0 (sv) Receptors
DE59914061D1 (de) Das gen prv-1 und dessen verwendung
EP0945512A3 (de) Serinproteasen
DE69519654D1 (de) htFIIIA Gen
ATE301199T1 (de) Beta-primeverosidase gen
EP1251172A4 (de) Mit wt1 interagierendes protein, wtip
HUP0002349A2 (hu) Citokinin oxidáz enzim és alkalmazásai
WO1999007739A3 (en) Dna encoding the human synapsin iii gene and uses thereof
WO1999060117A3 (fr) Polypeptide prax-1

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties